Covid-19 vaccine

Study: Covid-19 Vaccine Does Not Increase Risk Of Preterm Birth

Pregnant people who contract COVID-19 have an increased risk of disease severity and death, yet only 31 per cent of pregnant people in the United States had received vaccines as of September 2021. One barrier to vaccine acceptance is the concern that vaccination might disrupt pregnancy.

The findings were reported by the Centers for Disease Control and Prevention (CDC). A Yale co-led study, which looked at more than 40,000 pregnant individuals, adds new evidence supporting the safety of COVID-19 vaccination during pregnancy.

The study found COVID-19 vaccination during pregnancy was not associated with preterm birth or small-for-gestational-age (SGA) when comparing vaccinated with unvaccinated pregnant people.

The trimester when the vaccination was received and the number of COVID-19 vaccine doses received were also not associated with increased risk of preterm birth or SGA, the researchers found.

Preterm birth (in which babies are delivered earlier than 37 weeks) and SGA (in which babies are delivered smaller in size than normal for the gestational age) have been associated with a higher risk for infant death and disability. For the new study, the authors used data from eight health care organizations participating in Vaccine Safety Datalink — a project established by the CDC to monitor vaccine safety — to investigate the risk for preterm birth or SGA among vaccinated and unvaccinated pregnant women aged 16 to 49 years.

Among those included in the study, 10,064 individuals, or nearly 22 per cent, received at least one COVID-19 vaccine dose during pregnancy, researchers said. Most (98.3 per cent) received vaccination during their second or third trimester; the rest (1.7 per cent) received it during their first trimester of pregnancy.

Almost 96 per cent of those vaccinated received an mRNA vaccine developed by Pfizer-BioNTech or Moderna.

To date, a few studies have described outcomes among live births following COVID-19 vaccination in pregnancy, the researchers say. The new findings add to the evidence that COVID-19 vaccination is safe during pregnancy.

Research into the drivers behind low vaccine acceptance among pregnant people has found that the most common concerns have been a lack of information about COVID-19 vaccine safety in pregnant people and potential harm to the fetus. The results of this study speak to both, said Heather Lipkind, associate professor of obstetrics, gynecology, and reproductive sciences at the Yale School of Medicine and lead author of the study.

“Getting vaccinated against COVID-19 is important for preventing severe illness in pregnant people,” said Lipkind. “With the increasing rates of COVID-19 in our community we are encouraging pregnant people to get vaccinated.”

Pregnant individuals, in addition to seeing an increased risk of severe disease and death compared with non-pregnant people, are more likely to require admission into the intensive care unit, invasive ventilation, and machine-assisted blood oxygenation.

The CDC and the American College of Obstetricians and Gynecologists recommend the COVID-19 vaccine for people who are pregnant, breastfeeding, trying to get pregnant, or might become pregnant in the future.

France sees record 104,611 daily COVID-19 cases

Paris [France] (ANI/Sputnik): The French sanitary authority reported 104,611 new COVID-19 cases on Saturday, the highest daily toll seen in the country since the pandemic began.

France said daily infections surpassed 94,100 on Friday and 58,500 last Saturday.
Health Minister Olivier Veran said that the Omcron strain was set to become the dominant variant in France by the end of the year but stopped short of toughening COVID-19 restrictions. (ANI/Sputnik)

Matthew McConaughey: No to vaccine for Kids

Oscar-winning actor Matthew McConaughey doesn’t support a COVID-19 vaccine mandate for kids just yet.

Nearly a week after the US Centers for Disease Control and Prevention formally authorised Pfizer’s vaccine for use in children ages 5 to 11, McConaughey, who is fully vaccinated, explained that he isn’t anti-vaccine but wants “to find out more information” before supporting any requirements that young children get the shot. “We just said we can vaccinate kids. I want to trust in the science,” the 52-year-old actor said during The New York Times’s DealBook summit on Tuesday, reported People magazine.
The actor continued, “Do I think that there’s any kind of scam or conspiracy theory? Hell no I don’t. We all got to get off that narrative. There’s not a conspiracy theory on the vaccines.”

McConaughey and his wife Camila Alves share sons Levi, and Livingston, and daughter Vida. On Tuesday, he explained that the couple had chosen to “go slow” with vaccinating their children “even before COVID”.

McConaughey and Alves are both fully vaccinated. His 90-year-old mother Kay, who lives with the family, is also vaccinated and has received a booster shot, he said. For the time being, he said he won’t be vaccinating his young children: “Right now, I’m not vaccinating [my young children], I’ll tell you that.”

“I didn’t do it because someone told me I had to,” he said of receiving the shot himself. “I chose to do it.”
The ‘Dallas Buyers Club’ star emphasised that he and his family have taken the pandemic seriously and have relied heavily on at-home testing to keep everyone safe — and stressed that his priority is protecting his elderly mother, who is immunocompromised and has been staying with them throughout the pandemic.

He said that they’ve “quarantined harder than any of our friends have and still are two years later.”
“I’m in a position though where I can do that, and I understand not everyone can do that,” he said.

“I couldn’t mandate having to vaccinate the younger kids. I still want to find out more information,” he added.

“There’s gonna come a time, though — and there has already in these last two years, obviously — there’ll come a time where you’re gonna have to roll the dice one way or the other and go, where are the numbers in my favour? I’m vaccinated. Wife’s vaccinated. … We’re over here just trying to live as healthy a lifestyle as possible, but I couldn’t mandate it for kids just yet,” the actor further said.

Over 107.92 cr COVID-19 vaccine doses administered so far in India

New Delhi [India] : India has administered over 107.92 crore COVID-19 vaccine doses so far under the nationwide vaccination drive, the Ministry for Health and Family Welfare informed on Saturday.
As per the ministry, 1,07,92,19,546 vaccines doses have been administered in the country so far. Meanwhile, India reported 10,929 new COVID-19 cases in the last 24 hours. The country’s active caseload stands at 1,46,950 the lowest in 255 days.
Active cases account for less than one per cent of total cases, currently at 0.43 per cent, lowest since March 2020.
With 12,509 recoveries in the last 24 hours, the total recoveries in the country have been increased to 3,37,37,468. The recovery rate is currently at 98.23 per cent which is the highest since March 2020.
The daily positivity rate is 1.35 per cent which is less than two per cent for the last 33 days and the weekly positivity rate stands at 1.27 per cent which is less than two per cent for the last 43 days.
According to the Indian Council of Medical Research (ICMR), 8,10,783 samples were tested for the presence of the virus in the last 24 hours taking the cumulative tests conducted in the country to 61,39,65,751.

‘Har Ghar Dastak’ Campaign

New Delhi [India] : Union Health Minister Mansukh Mandaviya on Wednesday said that the Centre has started ‘Har Ghar Dastak’ campaign to increase COVID-19 vaccination coverage.
Lauding the efforts of Prime Minister Narendra Modi, he said that effective measures have been taken to curb COVID-19 and people across the world have appreciated India’s achievement of administering over 100 crore vaccine doses. “Prime minister Narendra Modi has taken effective steps for the protection of every countrymen from Corona. The whole world appreciated India’s historic achievement of 100 crore vaccinations. Modi government, determined to provide security to the people, today ‘Har Ghar Dastak’ Started the campaign, which we will take to every household,” Mandaviya tweeted in Hindi.
Immediately after returning from his visit to Italy and Glasgow, the Prime Minister held a review meeting with districts having low vaccination coverage.
The meeting included districts with less than 50 per cent coverage of the first dose and low coverage of the second dose of the Covid vaccine.
The Prime Minister interacted with District Magistrates of over 40 districts in Jharkhand, Manipur, Nagaland, Arunachal Pradesh, Maharashtra, Meghalaya, and other states with districts having low vaccination coverage.
During the interaction, the Prime Minister urged the healthcare workers to reach every house with passion ‘har ghar tika, ghar ghar tika’ – vaccine at every doorstep. He also asked to go in the spirit of ‘Har Ghar Dastak’ knocking on every doorstep to ensure full vaccination. “Now we are preparing to take the vaccination campaign to each household. With the mantra of ‘Har Ghar Dastak’, knock on every door, every household lacking the security net of a double dose of vaccine will be approached” he said.
Earlier, announcing the launch of the ‘Har Ghar Dastak’ campaign, the Health Minister had said “We are going to launch a mega vaccination campaign We have decided that for the next one month, healthcare workers will go door-to-door to vaccinate people eligible for the second dose and also those who have not taken the first dose.”

Australia adds Covaxin to list of ‘recognised’ COVID-19 vaccines

Canberra [Australia] : Australian government on Monday gave recognition to Bharat Biotech’s Covaxin COVID-19 vaccine for the purpose of establishing a traveller’s vaccination status in the country.
“Today, the Therapeutic Goods Administration determined that Covaxin (manufactured by BharatBiotech) vaccine would be ‘recognised’ for the purpose of establishing a traveller’s vaccination status,” Australia’s High Commissioner to India Barry O’Farrell informed in a tweet. “Importantly, recognition of Covaxin, along with the previously announced recognition of Covishield (manufactured by AstraZeneca India, means many citizens, as well as other countries, will now be considered fully vaccinated on entry to Australia,” the High Commissioner added in the tweet.
COVID-19 vaccines are approved for use in Australia by the Therapeutic Goods Administration (TGA) after an assessment and approval process.


“In recent weeks, the TGA has obtained additional information demonstrating these vaccines provide protection and potentially reduce the likelihood that an incoming traveller would transmit COVID-19 infection to others while in Australia or become acutely unwell due to COVID-19,” a statement from Australia’s Department of Health informed.
Recognition of Covaxin, along with the previously announced recognition of Covishield (manufactured by AstraZeneca, India), means many citizens of India, as well as other countries where these vaccines have been widely deployed, will now be considered fully vaccinated on entry to Australia, the statement said.
“This will have significant impacts for the return of international students, and travel of skilled and unskilled workers to Australia,” the statement added.
From 1 November 2021, vaccinated Australians and permanent residents aged 12 and over may depart Australia without the need to seek a travel exemption, the Australian Health Department said.
The UN health body — World Health Organisation — has sought additional clarifications from Bharat Biotech, which manufactures Covaxin and a decision on emergency use authorisation is expected early next month.
WHO giving approval for Emergency Use Authorisation for India’s indigenous COVID-19 vaccine ‘Covaxin’ would facilitate the process of assisting other countries, Foreign Secretary Harsh Vardhan Shringla said on Saturday addressing a media briefing on the first day of G20 summit in Rome.

PM Modi to interact with COVID-19 vaccine manufacturers today

New Delhi [India] : Prime Minister Narendra Modi is set to interact with the seven Indian manufacturers of the COVID-19 vaccine on Saturday, days after the country crossed a milestone of administering 100 crore vaccinations.
During the interaction, the PM will take stock of the experiences of the manufacturers as well as discuss various issues like furthering vaccine research. As per the Ministry of Health and Family Welfare, with the administration of 68,48,417 vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage has surpassed the 100 Crore mark to reach 101.30 Cr (1,01,30,28,411) as per provisional reports till 7 am today.

‘Centre changed vaccine policy:Owaisi

Taking a dig at Prime Minister Narendra Modi’s remark on VIP culture in vaccination campaign, All India Majlis-e-Ittehadul Muslimeen (AIMIM) chief Asaduddin Owaisi on Friday alleged that the Centre left the state and the people to their fate and changed their COVID-19 vaccine policy only after the intervention of the Supreme Court.

New Delhi [India] : In a series of tweets, Owaisi said that PM Modi placed the first vaccine order just five days before the campaign began. “Modi: No VIP culture in the vaccination campaign. Only India has an exclusive corporate sector vaccine QUOTA of 25 per cent. Modi placed the first vaccine order just FIVE days before the campaign began. He left states and the people to their fate. He changed the policy because SC intervened,” said Owaisi.
He further said that this incompetence and absence of vision cost lakhs of lives in the second wave. “We lost our loved ones. We should never forget the lives lost due to neglect and lack of compassion,” he added.
Earlier today, Prime Minister Narendra Modi said the Central government ensured that VIP culture does not overshadow India’s COVID-19 vaccination programme.
Addressing the nation, the Prime Minister said, “We ensured that VIP culture does not overshadow our vaccination programme and everyone is treated equally.”
On October 21, India achieved the landmark target of administering 100 crore COVID-19 vaccine doses.

100 cr COVID vaccination is fine, but what about inflation, unemployment, questions Yechury

New Delhi [India] : While appreciating the Central government for achieving the landmark of administering over 100 crore Covid-19 vaccine jabs, Communist Party of India (Marxist) General Secretary Sitaram Yechury on Friday raised concern over rising fuel prices, unemployment and hunger.
Speaking to ANI, Yechury said, “I congratulate the countrymen on this accomplishment. However, I believe that only 21 per cent of the population is administered with the second dose of the Covid-19 vaccine. In today’s address to the nation, the Prime Minister did not speak on issues like rising fuel prices, unemployment and hunger in the country.” Yechury further said, “Vaccine century is an achievement in itself but one must know that there are only two countries in the world that have a population of more than 125 crores. The other country (hinting at China), has administered more shots of the second dose as compared to ours. Previously, the Prime Minister had given the assurance that by the end of the year, all the adults in the country will be vaccinated but this assurance seems far-fetched.”

oa


Pointing out issues like rising fuel prices, unemployment and hunger, the CPI(M) leader said, “People have so many problems. The Prime Minister did not mention any problem. The prices of petrol and diesel are increasing every day, farmers’ agitation is going on since a year, the Lakhimpur Kheri incident happened, unemployment is increasing, hunger is increasing, more than 10 million tonnes of food grains are lying in Central godown…. why is the government not distributing it? All these important issues which are related to the everyday life of people.”
Meanwhile, India achieved the landmark of administering 100 crore Covid-19 vaccines on Thursday. Following the development, PM Modi addressed the nation today congratulating people over this accomplishment in the fight against the pandemic.

India crossing 100 crore COVID-19 vaccinations big achievement, says Piyush Goyal

New Delhi [India] : Union Commerce and Industry Minister Piyush Goyal on Thursday said that India crossing 100-crore COVID vaccinations is a big achievement and the country will be soon able to vaccinate all its citizens with the first dose of vaccine.
He said there are sufficient vaccine stocks available for those eligible for second dose of vaccine. “Under the leadership of Prime Minister Narendra Modi, touching 100-crore COVID vaccination is a big achievement. It is clear that India would soon vaccinate all its citizens with the first dose of vaccine. There are sufficient vaccine stocks available for the second dose,” Goyal told ANI.
“The PM is personally monitoring the vaccination drive in the country. PM Modi had one-to-one interaction with all the scientists and encouraged them to develop anti-COVID vaccines,” he added.
Goyal said the medical staff took this vaccine to different corners of the country.
India’s cumulative COVID-19 vaccination coverage crossed 100 crore doses on Thursday.

Let’s give govt credit : Shashi Tharoor

The CoWin portal on Thursday mentioned that a total of 100 crore vaccine doses has been administered so far to the eligible population under the vaccination drive in India.

News delhi( India ) : After India on Thursday achieved a major milestone of 100 crore vaccination, Congress MP Shashi Tharoor said that the credit should be given to the government and this is a matter of pride for the entire country.

“This is a matter of pride for all Indians. Let’s give the Government credit. After severe mismanagement of the second #Covid wave & botching the vaccination orders that might have prevented it, Govt has now partly redeemed itself. It remains accountable for its earlier failures,” Tharoor said in a tweet.

The CoWin portal on Thursday mentioned that a total of 100 crore vaccine doses has been administered so far to the eligible population under the vaccination drive in India.

India’s vaccination drive against the Covid pandemic was launched on January 16, 2021. The healthcare workers were the first ones to get doses. Later, the frontline workers were also included in the drive from February 2. The state and central police personnel, Armed Forces, Home Guards, Civil Defence and others were included in the vaccination drive.

The vaccination drive was expanded from March 1 to include people above 60 years of age and those above 45 years with associated specified comorbidities. From May 1, the vaccination drive was thrown open to all above 18 years of age.

Prime Minister Modi said in a tweet, “India scripts history. We are witnessing the triumph of Indian science, enterprise and collective spirit of 130 crore Indians. Congrats India on crossing 100 crore vaccinations. Gratitude to our doctors, nurses and all those who worked to achieve this feat.

Kejriwal lauds healthcare, frontline workers

New Delhi [India] : As India’s COVID-19 vaccination coverage surpassed the 100 crore mark on Thursday, Aam Aadmi Party chief and Delhi Chief Minister Arvind Kejriwal lauded the efforts of the healthcare and frontline workers.
Taking to Twitter, Kejriwal said, “Congratulations to all the countrymen on administering 100 crore vaccines. Salute to the doctors, nurses and frontline workers who made this possible. All of us countrymen together faced this disease. Together we will defeat this forever.” India’s COVID-19 vaccination drive was launched on January 16, 2021.
Initially, the vaccination was opened for Health Care Workers (HCWs) only.
From February 2, front line workers were made eligible for vaccination. These included State and Central Police personnel, Armed Force Personnel, Home Guards, Civil Defence & Disaster Management Volunteers, Municipal workers, Prison Staff, PRI Staff and Revenue workers involved in containment and surveillance, Railway Protection Force and election Staff.
The vaccination drive was expanded from March 1 to include persons above 60 years of age and those above 45 years with associated specified 20 comorbidities. It was further expanded to all people above 45 years of age from April 1. From May 1, all persons above 18 years of age were made eligible for COVID-19 vaccination.
Earlier in the day, Prime Minister said, “India scripted history” as the vaccination figure surpassed 100 crore mark.

Over 103 crore COVID-19 vaccine doses provided to States, UTs: Centre

New Delhi [India],3): The government has provided more than 103.5 crore COVID-19 vaccine doses to States and union territories (UTs), said the Union Health Ministry on Thursday.
A total of 1,03,53,51,045 vaccine doses have been provided to States and UTs so far through the Government of India (free of cost channel) and through the direct state procurement category, said the ministry in an official statement. It further stated that more than 10.85 crore (10,85,69,250) balance and unutilized COVID vaccine doses are still available with the States and UTs to be administered.
Meanwhile, India’s cumulative COVID-19 vaccination coverage crossed 100 crore on Thursday at 9.47 am.
India started its COVID-19 vaccination drive on January 16 this year.
“As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID-19 vaccination drive, the Union Government will procure and supply (free of cost) 75 per cent of the vaccines being produced by the vaccine manufacturers in the country to States and UTs,” said the ministry.

India now has strong armour of 100 cr COVID vaccine to combat biggest pandemic in 100 yrs: PM Modi

As India achieved the milestone of 100 crore vaccination coverage, Prime Minister Narendra Modi said it was a historic day for the country and said that the nation now has strong armour of 100 crore COVID vaccine doses to combat the biggest pandemic in 100 years.

New Delhi [India] : Addressing the launch event of the Infosys Foundation made 806-bedded Vishram Sadan, PM Modi said, “Today, this day of October 21, 2021, has been recorded in history. The nation now has strong armour of 100 crore Covid vaccine doses to combat this biggest pandemic in 100 years. India has crossed the 100 crore vaccine dose mark sometime back.” The Prime Minister further said that this achievement belongs to every citizen of India.
“I express my gratitude to all the vaccine manufacturing companies of the country, workers engaged in vaccine transportation, health sector professionals engaged in vaccine development,” the prime minister said.


In a landmark achievement, India’s cumulative COVID-19 vaccination coverage crossed 100 crore doses on Thursday. A total of 100 crore vaccine doses have been administered so far to eligible beneficiaries, as per the CoWIN portal at 9:47 am today.
India’s COVID-19 vaccination drive was launched on January 16, 2021.
Initially, the vaccination was opened for Health Care Workers (HCWs) only.
From February 2, front line workers were made eligible for vaccination. These included State and Central Police personnel, Armed Force Personnel, Home Guards, Civil Defence & Disaster Management Volunteers, Municipal workers, Prison Staff, PRI Staff and Revenue workers involved in containment and surveillance, Railway Protection Force and election Staff.
The vaccination drive was expanded from March 1 to include persons above 60 years of age and those above 45 years with associated specified 20 comorbidities. It was further expanded to all people above 45 years of age from April 1. From May 1, all persons above 18 years of age were made eligible for COVID-19 vaccination.

Corporate, private sectors have continuously contributed to strengthening health services: PM Modi

New Delhi [India] : Prime Minister Narendra Modi on Thursday said that India’s corporate sector, private sector and social organizations have continuously contributed to strengthening the healthcare services of the country.
“India’s corporate sector, private sector and social organizations have continuously contributed to strengthening the health services of the country. Ayushman Bharat Pradhan Mantri Jan Arogya Yojana is also a great example of this,” said PM Modi, while addressing at the launch event of Infosys Foundation Vishram Sadan. He said, “When the patient gets free treatment under the Ayushman Bharat scheme, then an act of service is accomplished. It is this service motive that has made the government take steps to reduce the prices of about 400 cancer medicines.”
The Prime Minister further praised the Infosys Foundation for constructing the building of Vishram Sadan and AIIMS Jhajjar for providing the land, electricity and water.
He expressed his gratitude to the AIIMS management and Sudha Murthy’s team for this service.
“Today in AIIMS Jhajjar, patients coming for cancer treatment has got a great convenience. This Vishram Sadan, built in the National Cancer Institute, will reduce the worries of patients and their relatives,” he said.
The Prime Minister also expressed his gratitude to all the vaccine manufacturing companies of the country, workers engaged in vaccine transportation, health sector professionals engaged in vaccine development.
“Today is a historic day as India has crossed the 100 crore vaccine dose mark. To counter the largest pandemic in 100 years, the country now has a strong protective shield of 100 crore vaccine doses. This achievement belongs to India and its citizens,” he added.
Union Health and Family Welfare Minister, Mansukh Mandaviya, Haryana Chief Minister Manohar Lal Khattar and Chairperson of Infosys Foundation, Sudha Murthy, were also present on the occasion.
The 806 bedded Vishram Sadan, is a part of Infosys’ Corporate Social Responsibility, to provide air-conditioned accommodation facilities to the accompanying attendants of the Cancer Patients, who often have to stay in hospitals for a longer duration, as per the press note released by the Prime Minister’s Office.
“It has been constructed by the Foundation at a cost of about Rs 93 crore. It is located in close proximity to the hospital & OPD Blocks of NCI,” the release added.

More than 101.7 cr vaccine doses provided to states, UTs so far: Centre

New Delhi [India] : More than 101.7 crore COVID-19 vaccine doses have been provided to states and union territories, out of which, over 10.42 crore balance and unutilised doses are still available with them, informed the Ministry of Health and Family Welfare on Sunday.
According to the ministry, the Centre has provided 1,01,78,96,755 vaccine doses to all the states and union territories so far (free of cost channel) through the direct state procurement category. It further stated that more than10.42 crore (10,42,45,455) balance and unutilised COVID-19 vaccine doses are still available with the States, UTs to be administered.
Meanwhile, India reported 14,146 fresh COVID-19 infections in the last 24 hours.
The daily infection count is lowest in 229 days marking the daily positivity rate at 1.29 per cent. The new cases pushed the cumulative number of COVID cases in the country to 3,40,67,719.
As many as 19,788 patients have been recovered in the last 24 hours taking the total number of recoveries to 3,34,19,749. The current recovery rate is 98.10 per cent, the highest since March 2020Meanwhile, the country’s active caseload stands at 1,95,846 which is said to be the lowest in 220 days.

India to procure over 30 crore COVID-19 vaccine doses per month by January : Sources

India will have a vaccine capacity of 28 crore doses this month, which includes 22 crore Serum Institute of India’s Covishield and 6 crore doses of Bharat Biotech Biotech’s Covaxin and production of 60 lakh Zydus Cadila’s ZyCoV-D doses are also ready, said government sources. India will have a capacity of more than 30 crores by next year per month, which includes Covishield, Covaxin, ZyCoV-D and Biological E.

New Delhi [India] : According to the sources, the production of 60 lakh doses of Zydus Cadila’s ZyCoV-D are already ready with the company and Biological E will be submitting the data till November end of phase -3 trials. The Biological E is the third Indian company to make Covid-19 vaccines. The company has also started stockpile doses.
Biological E will be providing 30 crore doses and another company that is expected to provide doses is Gennova which is the fourth Indian company doing trials of mRNA vaccines. India is expected to get Gennova’s mRNA vaccine doses by February.
Earlier, on September 2, NITI Aayog Member (Health) VK Paul had said that the Hyderabad-based pharmaceutical company, Biological E, is expected to launch its vaccine against coronavirus in October this year.
Paul had told that Phase 3 of Biological E’s trial is underway. “Stockpile is being produced. We should wait for the results. We hope it’ll be in the next month or two. They’ve made a broad commitment that they’ll supply a significant amount by year-end.”
India procured more than 26 crore doses in the month of September also.
Centre plans to achieve 100 crore doses in next week.
Earlier, it was expected to reach the target between October 10 to October 12. The delay and decline in Covid vaccination are due to the festival season and hesitation in the second dose.
India may accelerate the export of Covid-19 vaccines under its humanitarian initiative ‘Vaccine Maitri’ by December after having an excess number of doses in the country.

Bharat Biotech awaits feedback from WHO for COVID-19 vaccine Covaxin’s emergency use listing

Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its COVID-19 vaccine Covaxin and is awaiting feedback from the UN Public Health Agency.

New Delhi [India], September 17 : In a series of tweets, Bharat Biotech said that Covaxin clinical trial was fully compiled and available in June 2021. “#COVAXIN clinical trial data was fully compiled and available in June 2021. All Data was submitted for Emergency Use Listing (EUL) Application to World Health Organization in early July. We have responded to any clarifications sought by #WHO and are awaiting further feedback,” Bharat Biotech tweeted.
As a responsible manufacturer with past approvals for its other vaccines, the company said it would not find it appropriate to speculate or comment on the approval process and its timelines, it further said.
“We are continuing to work diligently on obtaining WHO EUL at the earliest,” it added.
Earlier on Monday, the sources said that the World Health Organisation’s (WHO) approval for Covaxin, is expected this week.
Bharat Biotech has submitted its Phase 3 clinical trials data that demonstrated 77.8 per cent efficacy to the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
Earlier in June, a pre-submission meeting for WHO Emergency Use Listing Procedure (EUL), which provides advice before the submission of the final dossier, was also held.
Union Health Minister Mansukh Mandaviya had also earlier met WHO Chief Scientist Dr Soumya Swaminathan and held discussions over the approval of Bharat Biotech’s Covid-19 vaccine Covaxin.
Covaxin was developed by Hyderabad-based Bharat Biotech in association with the Indian Council of Medical Research and the National Institute of Virology. Covaxin, which has been developed in collaboration with the Indian Council of Medical Research (ICMR), contains a whole virion inactivated SARS-CoV-2 vaccine, which is produced in Vero cells.
The vaccine is stable at 2 degrees Celsius to 8 degrees Celsius (refrigerated) and is shipped in a ready-to-use liquid formulation that permits distribution using existing vaccine supply chain channels.
The WHO has approved COVID-19 vaccines by Pfizer-BioNTech, AstraZeneca, Johnson and Johnson, Moderna and Sinopharm.

Zydus Cadila to seek approval for two-dose regimen of its approved three-dose COVID-19 vaccine in India

Considering the burden on healthcare and the expense of buying three doses, Zydus Cadila is planning to seek approval for the two-dose regimen of its needle-free COVID-19 vaccine, ZyCoV-D, days after the vaccine was approved by India’s drugs regulator for emergency use in India on August 20.

New Delhi [India], September 12 : The trials for the two-dose regimen are underway. 2mg of the vaccine has been prescribed in each dose of the present-day three-dose vaccine i.e. total of 6 mg. The company is now evaluating a 2 dose regime with 3mg in each dose.
The vaccine is said to be pathbreaking as it is for the first time that a technologically advanced vaccine has been successfully developed on the Plasmid DNA platform for human use.
A plasmid DNA vaccine uses non-replicating DNA molecules. As per Zydus Cadila, the vaccine which when administered produces the spike protein of the SARS-CoV-2 virus and elicits an immune response mediated by the cellular and humoral arm of the human immune system, which plays a vital role in protection from disease as well as viral clearance.
The platform because of its rapid plug-and-play technology can be easily adapted to deal with mutations in the virus, such as those already occurring. The company plans to manufacture 10-12 crore doses of ZyCoV-D annually.
The vaccine is stored at 2-8 degrees Celsius. Unlike Pfizer and Moderna vaccines that need to be stored at a very cold temperature, ZyCoV-D can be stored at 2 to 8 degrees. This vaccine is also effective against the Delta variant of COVID-19.
ZyCoV-D is needle-free and is administered intradermally which is done using PharmaJet, a needle-free applicator that ensures painless vaccination. This will help in administering the vaccine to kids.
The vaccine is likely to be available by early October, sources told ANI on Saturday.
Recently in an exclusive interview with ANI, Dr Sharvil Patel, Managing Director of Zydus Group said that the supply of the vaccine will start from October onwards.
“The supply of vaccine will begin by mid-September and from October onwards, the supply will be scaled up to one crore doses per month,” Patel had said.
On expected supply of vaccine till December, Patel said the company is expecting to scale up 1 crore doses per month from October and it will supply 4-5 crore doses per month till January 2022.
“We can scale up production of a vaccine up to 1 crore a month from October at the new production plant, and it is expected to supply 4-5 million doses till January 2022,” he had said,
According to the Ministry of Health and Family Welfare (MoHFW), with the administration of 72,86,883 vaccine doses in the last 24 hours, the country’s COVID-19 vaccination coverage surpassed the cumulative figure of 73.82Cr (73,82,07,378) as per provisional reports till 7 am on Sunday. This has been achieved through 75,25,766 sessions, stated the ministry.
Currently, Covishield, Covaxin, and Sputnik V vaccines are being administered to the eligible population above 18 years.

India logs 43,263 fresh cases

The total active cases of COVID in India rose to 3,93,614, the ministry data showed.over 40,000 recoveries in 24 hours

New Delhi [India], September 9 : A total of 43,263 new COVID-19 cases and 338 deaths were reported across the country in the last 24 hours, informed the Union Health Ministry.
Of these, Kerala recorded 30,196 cases and 181 deaths. The Health Ministry said that India’s active caseload now stands at 3,93,614. The active cases account for 1.19 per cent of total cases, while the recovery rate is 97.48 per cent.
With 40,567 recoveries recorded in the last 24 hours, the cumulative recoveries have climbed to 3,23,04,618.
The total number of COVID-19 cases reported in the country has reached 3,31,39,981.
The weekly positivity rate at 2.43 per cent remains less than 3 per cent for the last 76 days now. The daily positivity rate is reported to be 2.38 per cent. It has been less than 3 per cent for the last 10 days.
In order to detect the presence of the virus in people, as many as 53.68 crore tests have been conducted so far.
Meanwhile, in the ongoing nationwide COVID-19 vaccination drive, 71,65,97,428 vaccine doses have been administered to eligible beneficiaries, out of which 86,51,701 doses were administered in the last 24 hours.

India administers 70 crore COVID-19 vaccine doses till date

In a landmark achievement, India has administered 70,00,00,000 crore COVID-19 vaccine doses to date, informed Union Health Minster Mansukh Mandaviya on Tuesday.

New Delhi [India], September 7 : Taking to Twitter, Mandaviya congratulated all the health workers and people for this momentous achievement. “Soaring higher on #COVID19 vaccination under PM @NarendraModi ji’s leadership. 70,00,00,000 vaccine doses administered to date. Congratulations to all the health workers and people for this momentous achievement. #SabkoVaccineMuftVaccine,” the health minister said in a tweet.
Earlier on Monday, India administered more than one crore doses of COVID-19 vaccine in a day.
“September has started on a high note as India touches 1 crore Covid-19 vaccinations today. Under PM Narendra Modi’s leadership, the world’s largest vaccination drive is scaling massive heights,” Union Health Minister tweeted on Monday.
Prime Minister Narendra Modi also lauded the administration of over one crore COVID-19 vaccine doses in a day.
India had started the COVID-19 vaccination drive on January 16 with two vaccines — Covishield (Oxford-AstraZeneca’s vaccine manufactured by Serum Institute of India) and Covaxin (manufactured by Bharat Biotech Limited).
The second phase of the COVID-19 vaccination drive to inoculate people above 60 years and those over 45 with comorbidities against the coronavirus began on March 1.
The third phase began on April 1 for all above 45 years of age. In the next phase that began from May 1, all above the age of 18 were eligible to receive the shot.

Delhi reports 38 new COVID-19 cases, 4 deaths in the last 24 hours

New Delhi [India]: The national capital on Tuesday saw a slight surge in its daily count reporting 38 new COVID-19 cases and four fatalities in the last 24 hours.


As per the Delhi health bulletin, a total of 53,345 tests were conducted in the last 24 hours wherein a positivity rate of 0.07 per cent was reported. The total cases mounted to 14,37,156 including 471 active cases. As a sign of relief, 30 recoveries were logged thereby escalating the total recoveries to 14,11,612.


However, the death toll touched 25,073 including new deaths with 1.74 per cent case fatality rate.
As far as the COVID-19 vaccination status in the national capital is concerned, cumulative beneficiaries vaccinated so far stand at 1,16,59,932 wherein 1,56,217 beneficiaries were vaccinated in the last 24 hours.
Yesterday, Delhi reported 27 new COVID-19 cases which was the lowest daily count in this year so far.

India achieves highest single day COVID-19 vaccination mark

With over 88.13 lakh COVID-19 vaccine doses administered in the last 24 hours, India has achieved the highest single-day vaccination mark on Monday.

New Delhi [India], August 17 : “88 lakh India achieves the highest single-day record in #COVID19 vaccine doses. Yesterday will go down in the history of the world’s #LargestVaccineDrive. Congratulations [India],” Union Health Minister Mansukh Mandaviya tweeted on Tuesday. The COVID-19 vaccination coverage in India has also crossed the 55-crore mark.
“Cumulatively, 55,47,30,609 vaccine doses have been administered through 62,12,108 sessions, as per the provisional report till 7 am today,” Union Health Ministry informed.
At present, India’s recovery rate is the highest since March 2020; standing at 97.51 per cent.
“Out of the people infected since the beginning of the pandemic, 3,14,48,754 people have already recovered from COVID-19 and 36,830 patients have recovered in the last 24 hours,” the ministry said.
In the last 24 hours, India has recorded 25,166 new COVID-19 cases, its lowest daily new cases in 154 days. The active caseload in the country is at 3,69,846, the lowest in 146 days, constituting only 1.15 per cent of the country’s total positive cases.
The ministry further informed that with substantially ramped up testing capacity across the country, a total of 15,63,985 tests were conducted in the last 24 hours in the country. Cumulatively, India has conducted over 49.66 crore (49,66,29,524) tests so far.
“While on one side testing capacity has been enhanced across the country, weekly positivity rate at 1.98 per cent remains less than 3 per cent for last 53 days now. The daily positivity rate also stands at 1.61 per cent. Daily positivity rate has remained below 3 per cent for the last 22 days and below 5 per cent for 71 consecutive days now,” the ministry added.

Over 2.25 cr unutilised COVID-19 vaccine doses available with States, UTs: Centre

New Delhi [India], August 17 : Union Health Ministry on Tuesday informed that over 2.25 crore balance and unutilised COVID-19 vaccine doses are available with the States, Union Territories and private hospitals, and are yet to be administered.
“More than 2.25 Cr (2,25,52,523) balance and unutilized COVID Vaccine doses are still available with the States/UTs and private hospitals to be administered,” the ministry said. Further, the ministry informed that the government has provided over 56.81 crore doses of COVID-19 vaccine to the states and UT’s till date, while over 1 crore are still in pipeline.
“More than 56.81 crore (56,81,32,750) vaccine doses have been provided to States/UTs so far, through all sources and a further 1,09,32,960 doses are in the pipeline,” the ministry stated.
Of the total COVID-19 vaccine doses provided, the total consumption including wastage, as per the ministry, is 55,11,51,992 doses, as per data available at 8 am today.

Arunachal reports 180 new Covid-19 cases, tally mounts to 50,973

Itanagar, Aug 13: Arunachal Pradesh Covid-19 caseload rose to 50,973 as 180 people have tested positive for the virus in the last 24 hours.
According to the bulletin issued by the state Directorate of Health Services, of the new positive cases, Itanagar Capital Complex reported the maximum at 62, followed by Papum Pare 19, East Siang and Lower Subansiri 13 each.
Eight cases were also reported from Changlang, West Kameng seven, Namsai six, Kamle five, Anjaw and Lower Dibang Valley four each, Pakke Kessang and Upper Siang three each, East Kameng, Upper Subansiri and West Siang two each, Tawang and Tirap one each.
Of these, 103 patients are asymptomatic and 77 symptomatic.
As per the bulletin, 273 people were discharged in the last 24 hours, taking the total recoveries to 48,327. The recovery rate is over 94 per cent.
Active cases tally stands at 2,395. Death toll at 251.

40 lakh doses per day

Vaccine production in the country has been increased from 2.5 lakh doses per day to around 40 lakh doses per day, said Dr Bharati Pravin Pawar, Minister of State (MoS) for Health

New Delhi [India], August 7 : To vaccinate the entire eligible population against COVID-19 as soon as possible, the vaccine production in the country has been increased from 2.5 lakh doses per day to around 40 lakh doses per day, said Dr Bharati Pravin Pawar, Minister of State (MoS) for Health on Friday.
Speaking to ANI, the MoS informed that trials are underway for the COVID vaccine for children. “Initially, around 2.5 lakh vaccines were produced per day. Today it has increased to around 40 lakhs per day. I think with this rise in the production capacity, we will be able to vaccinate people in an even better manner,” said Pawar.
She said that it is a matter of pride that vaccination numbers crossed the 50 crore mark in the country, and added that through (media), the government is spreading the message that vaccination is important in the fight against Corona.
The Minister emphasised that the government has made continuous efforts to ensure that vaccines reach people and informed that trials of vaccines for children are underway.
“Centre is making continuous efforts towards this. The vaccine is prepared on basis of efficacy, immunogenicity, and other parameters. Trials (of vaccines for Children) are underway keeping safety measures in mind. We’re trying to introduce it soon,” she added.
Pawar appreciated the role of media during the COVID pandemic and said the Centre will always stand with media persons and their families for risking their lives while reporting from the ground.

Health Minister Mandaviya meets Adar Poonawalla, discusses COVID vaccine supply ramping up

In order to ramp up COVID-19 vaccine supply in the country, Union Health Minister Mansukh Mandaviya on Friday met Serum Institute of India (SII) CEO Adar Poonawalla in the national capital and held a discussion over the supply of Covishield vaccine.

New Delhi [India], August 6 : “We had many good meetings here. We discussed ramping up vaccine production. More than 17 countries in Europe have already approved Covidshield and many are in line to give approval. We discussed also this. This will be good news for all the travellers also. We were doing what we can do for our students,” Poonawalla told ANI after the meeting with Union Health Minister. More than 136 crore COVID-19 vaccine doses are expected to be available till the end of this year, informed the central government on Friday.
For the next four months, India’s vaccine programme will be accelerated by the Serum Institute of India’s (SII) Covishield and Bharat Biotech’s Covaxin.
The note titled “Covid-19 Public Health Response Pro-active, Pre-emptive and Graded Response guided by Epidemiological and Scientific Rigour” also gave details about the vaccine production targets, which are given to Members of Parliament from the Prime Minister’s Office (PMO).
As per the note, “In August the vaccine projection of Covaxin will be 2.65 crores, Covishield will be 23 crores and total a 25.65 crore doses will be produced in the month. In September the projection of Covaxin is 3.15 crore and Covishield will be 23 crores, which in total will be 26.15 crore doses. In October the total of 28.25 crore doses will be produced out of which Covaxin will be 5.25 crore and Covishield will be 23 crore doses.”
Additionally, 28.25 crore doses will be available in November, of which 5.25 crore will be of Covaxin and 23 crores of Covishield. In December the projection of Covaxin will be 5.25 crore and Covishield will be 23 crore doses, which in total will be 28.5 crore doses for the month.
As per an advance order placed by the Centre for August to December 2021, 75 per cent of Covishield vaccine doses will be procured at Rs 215.25 per dose at a total cost of Rs 8,071.87 crore.
The note has also mentioned the government will buy 28.5 crore Covaxin doses from Bharat Biotech at Rs 225.75 per dose at a cost of Rs 6,433.87 crore.
On Sputnik V production, the note said, “Sputnik V is not yet produced till July and it is expected to be manufactured 25 million doses in August, September, and October by Panacea. Thereafter there is no clarity/visibility as it depends on the bulk to be provided by Russia for filling. So, total production for the year can be expected to be 2044.16 million doses.”
The Union Health Ministry gave a presentation to MPs on the COVID situation in the country and action taken during the crisis.
“Due to ongoing field activities in terms of increased testing, surveillance, clinical management and other activities for more than one year, the health system witnessed fatigue,” it said.
The note has also mentioned, “Human resource crunch experienced during the second wave due to shortage of doctors and healthcare workers across urban areas.”
“Lack of COVID appropriate behaviour and complacency set in the community during opened economic activities, the virus spread rapidly across India,” it said.
“With an unexpected surge in cases, challenges in terms of infrastructure augmentation across the country, enhanced Oxygen supply, drugs requirement and other logistics came up,” it added.
Further, the note mentioned the management of medical Oxygen and the management of drugs during the second wave. 

Still waiting for green lights from India to deliver COVAX : US

India needs time to review its legal provisions.US vaccines have landed in countries across the world, including Pakistan, Nepal, Bhutan and Bangladesh.

The United States on Tuesday said that it is ready to ship its COVID-19 vaccines expeditiously when it has the green light from the Indian government which has told the Americans that it needs further time to review legal provisions related to accepting vaccine donations. “We are ready to ship those vaccines expeditiously when we have a green light from the Government of India,” State Department Spokesperson Ned Price told reporters at his daily news conference.

The Biden Administration has announced to share 80 million doses from its domestic stockpile with countries around the world, including India. In recent week, the US vaccines have landed in countries across the world, including Pakistan, Nepal, Bhutan and Bangladesh.

However, the vaccines to India could not be sent because the Indian government is yet to clear the necessary legal hurdles for such an emergency import.

“Before we can ship those doses, however, each country must complete its own domestic set of operational, of regulatory, and legal processes that are specific to each country. Now, India has determined that it needs further time to review legal provisions related to accepting vaccine donations,” Price said.

“Once India works through its legal processes, our donations of vaccines to India will proceed expeditiously. We would need to refer you to the Government of India on the status of its discussions with COVAX, which, in this case, is helping to facilitate that delivery,” he said.

“More broadly in the region, throughout South Asia, we’re donating millions of vaccines to Afghanistan, Bangladesh, Bhutan, Nepal, the Maldives, Pakistan, and Sri Lanka. Roughly 40 million doses have been delivered worldwide so far,” he added.

Responding to another question, Price said that the COVID-19 cooperation between the two countries is built on decades of successful partnership in health and biomedical research.

“We are partnering to strengthen the global response to COVID-19 on issues ranging from addressing infectious disease outbreaks to strengthening health systems to securing global supply chains,” he said.

“We recently welcomed an initiative to collaborate through the International Center of Excellence in Research focused on infectious diseases, and in this case that includes COVID-19 and other emerging threats. We look forward to an overarching MOU, a memorandum of understanding, to enhance health cooperation beyond that,” he added.

The two countries are further working on diagnostics, therapeutics, vaccines to combat the disease and to recognise the importance of manufacturing critical drugs during this time and making them accessible globally.

“We are able to do that because India’s pharmaceutical sector is strong, it’s well-established, it has played a central role in manufacturing vaccines for global use over some time. We are pleased that US pharmaceutical companies, in turn, are coordinating with their Indian counterparts since the beginning of the pandemic,” Price said.

“As you know, beyond this partnership, in the context of the Quad leaders’ summit, there was an agreement to work with India to boost manufacturing of Covid vaccines that would support a safe and effective and eventually universal distribution of vaccines around the world,” he said.

Karnataka Health Minister Sudhakar warns people that the second COVID wave is not over yet

Bengaluru : Karnataka Health and Medical Education Minister Dr K Sudhakar on Tuesday appealed to the people to be continue to be cautious warning that the second wave of COVID-19 was not completely over yet.
Speaking to media persons here he said that even those who have taken two doses of the vaccine should continue to take all precautionary measures. After the unlock huge crowds have been seen in the markets and religious places and therefore it is important that people should strictly follow the COVID-19 guidelines or else they risk the possibility of inviting third wave, he said.
He said it was noticed that most of the people are not taking care and are moving around without masks and not maintaining social distancing in various places including tourist spots and suggested that people should not forget about the dangerous of spreading the virus.
He also said that a meeting with Chief Minister B S Yeddyiurappa later in the day will take a decision regarding imposition of night curfew.

First Covid Patient is +Again

The first India Covid Patient is presently at home and “she is OK” a doctor told reporters.

Thrissur: India’s first Covid patient, a medical student from Thrissur, Kerala has tested positive again for the virus. She was getting ready to leave for Delhi for study so her samples were tested. 

The RT-PCR result turned out to be positive, she is at home but is okay.

“She is reinfected with COVID-19. Her RT-PCR is positive, antigen is negative. She is asymptomatic,” Thrissur DMO Dr K J Reena told PTI. The woman is presently at home and “she is OK,” the doctor said.

According to an NCBI report, on January 27, 2020, the 20-year-old visited the Emergency Department in General Hospital, Thrissur, Kerala, with a one-day history of dry cough and sore throat she had no history of fever, rhinitis or shortness of breath.

The third-year medical student from Wuhan university tested positive for coronavirus, becoming the country’s first COVID-19 patient, days after she had returned home following semester holidays.

After nearly three weeks of treatment at the Thrissur Medical College Hospital, she had tested negative twice for the virus, confirming her recovery, and was discharged on February 20, 2020

India reports 37,154 cases

India recorded 37,154 new Covid-19 cases during the past 24 hours, pushing the country’s caseload to 3,08,74,376, while the death toll soared to 4,08,764 with 724 more fatalities, the Union Health Ministry said on Monday.

New Delhi : The active cases declined by 3,219 to stand at 4,50,899. It is now 1.46 per cent of the total caseload.

The past 24 hours saw 39,649 people recovering from the deadly virus, taking the total recovery count to 3,00,14,713, which is 97.22 per cent of the case tally. The fatality rate stood at 1.32 per cent.

Meanwhile, the Indian Council of Medical Research (ICMR) said that a total of 43,23,17,813 lakh samples have been tested so far for coronavirus. Of this, 14,32,343 were tested in the past day.

On the vaccination front, 37,73,52,501 people have been administered Covid-19 vaccines, with 12,35,287 being inoculated in the past 24 hours.

Zydus Cadila seeks Emergency Use Authorisation for its Covid-19 vaccine ZyCoV-D in India

Zydus Cadila seeks Emergency Use Authorisation for its DNA vaccine, ZyCoV-D, for 12 years and above in India.

Zydus Cadila has applied for Emergency Use Authorisation (EUA) nod from the Drugs Controller General of India (DCGI) for the launch of its DNA vaccine, ZyCoV-D, for 12 years and above. The company said that its vaccine has completed the third phase of trial.

If DGCA grants approval, ZyCoV-D will join Serum Institute of India’s Covishield, Bharat Biotech’s Covaxin and Russia’s Sputnik V vaccines to be authorized for emergency use in India.

According to the company’s claim, ZyCoV-D showed safety and efficacy during a late-stage trial . It involved more than 28,000 volunteers across the country. This included 1,000 subjects in the 12-18 year age group.

Zydus said that the study was carried out during the peak of second wave in India. It said that the drug is effective against the mutant strains especially the Delta variant which is prevalent in India.

Scroll to Top